No Bad Actor Disqualification. Neither Company, any predecessor of Company, any affiliate of Company, any director, executive officer, other officer of Company participating in the offering, or any beneficial owner of 20% or more of Company’s outstanding voting equity securities is subject to any bad actor disqualification as provided in Rule 506(d) of Regulation D, and Company is not aware of any facts or circumstances that, with the passage of time, would reasonably be expected to cause such disqualification.
Appears in 14 contracts
Samples: Stock Purchase Agreement (Camber Energy, Inc.), Loan Agreement (Camber Energy, Inc.), Stock Purchase Agreement (Camber Energy, Inc.)
No Bad Actor Disqualification. Neither Company, any predecessor of Company, any affiliate of Company, any director, executive officer, other officer of Company participating in the offering, or any beneficial owner of 20% or more of Company’s outstanding voting equity securities is subject to any bad actor disqualification as provided in Rule 506(d) of Regulation D, and Company is not aware of any current facts or circumstances that, with the passage of time, would reasonably be expected to cause such disqualification.
Appears in 10 contracts
Samples: Purchase Agreement (Generex Biotechnology Corp), Note Purchase Agreement (Inception Mining Inc.), Note Purchase Agreement (Inception Mining Inc.)
No Bad Actor Disqualification. Neither Company, any predecessor of Company, any affiliate of Company, any director, executive officer, other officer of Company participating in the offering, or any beneficial owner of 20% or more of Company’s outstanding voting equity securities is subject to any bad actor disqualification as provided in Rule 506(d) of Regulation D, and Company is not aware of any facts or circumstances that, with the passage of time, would reasonably be expected to cause such disqualification.D.
Appears in 6 contracts
Samples: Stock Purchase Agreement (6D Global Technologies, Inc), Stock Purchase Agreement (Amarantus Bioscience Holdings, Inc.), Stock Purchase Agreement (Amarantus Bioscience Holdings, Inc.)
No Bad Actor Disqualification. Neither Company, any predecessor of Company, any affiliate of Company, any director, executive officer, other officer of Company participating in the offering, or any beneficial owner of 20% or more of Company’s outstanding voting equity securities is subject to any bad actor disqualification as provided in Rule 506(d) of Regulation D, and Company is not aware of any facts or circumstances that, that with the passage of time, time would reasonably be expected to cause such disqualification.
Appears in 1 contract
